[Federal Register Volume 90, Number 204 (Friday, October 24, 2025)]
[Notices]
[Pages 48553-48554]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-19650]
========================================================================
Notices
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains documents other than rules
or proposed rules that are applicable to the public. Notices of hearings
and investigations, committee meetings, agency decisions and rulings,
delegations of authority, filing of petitions and applications and agency
statements of organization and functions are examples of documents
appearing in this section.
========================================================================
Federal Register / Vol. 90, No. 204 / Friday, October 24, 2025 /
Notices
[[Page 48553]]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Agency Information Collection Activities; Submission to the
Office of Management and Budget for Review and Approval; Comment
Request; Requirements for Patent Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence Disclosures
AGENCY: United States Patent and Trademark Office, Department of
Commerce.
ACTION: Notice of information collection; request for comments.
-----------------------------------------------------------------------
SUMMARY: The United States Patent and Trademark Office (USPTO) will
submit the following information collection request to the Office of
Management and Budget (OMB) for review and clearance in accordance with
the Paperwork Reduction Act of 1995, on or after the date of
publication of this notice. The USPTO invites comments on this
information collection renewal of 0651-0024 (Requirements for Patent
Applications Containing Nucleotide Sequence and/or Amino Acid Sequence
Disclosures), which helps the USPTO assess the impact of its
information collection requirements and minimize the public's reporting
burden. Public comments were previously requested via the Federal
Register on June 26, 2025, during a 60-day comment period (90 FR
27284). This notice allows for an additional 30 days for public
comment.
DATES: To ensure consideration, you must submit comments regarding this
information collection on or before November 24, 2025.
ADDRESSES: Written comments and recommendations for this information
collection should be submitted within 30 days of the publication of
this notice at the following website, www.reginfo.gov/public/do/PRAMain. Find this particular information collection by selecting
``Currently under 30-day Review--Open for Public Comments'' or by using
the search function and entering either the title of the information
collection or the OMB Control Number, 0651-0024. Do not submit
Confidential Business Information or otherwise sensitive or protected
information.
FOR FURTHER INFORMATION CONTACT:
This information collection request may be viewed at
www.reginfo.gov/public/do/PRAMain. Follow the instructions to view
Department of Commerce, USPTO information collections currently under
review by OMB.
Email: [email protected]. Include ``0651-
0024 information request'' in the subject line of the message.
Mail: Justin Isaac, Office of the Chief Administrative
Officer, United States Patent and Trademark Office, P.O. Box 1450,
Alexandria, VA 22313-1450.
Telephone: Raul Tamayo, Senior Legal Advisor, (571)-272-
7728.
SUPPLEMENTARY INFORMATION:
Agency: United States Patent and Trademark Office, Department of
Commerce.
Title: Requirements for Patent Applications Containing Nucleotide
Sequence and/or Amino Acid Sequence Disclosures.
OMB Control Number: 0651-0024.
Needs and Uses: Patent applications that contain nucleotide and/or
amino acid sequence disclosures falling within the definitions of 37
CFR 1.831 (for applications filed on or after July 1, 2022) or 37 CFR
1.821(a) (for applications filed on or before June 30, 2022) must
include, as a separate part of the application disclosure, a copy of
the sequence listing in accordance with the requirements in 37 CFR
1.831-1.835 or 37 CFR 1.821-1.825, respectively. Applicants may submit
sequence listings for both U.S. and international patent applications.
For more information concerning the submission of sequence listings in
international applications, see the Patent Cooperation Treaty (PCT)
Rules 5.2 and 13ter, Annex C of the PCT Administrative Instructions,
and section 1848 of the Manual of Patent Examining Procedure (MPEP)
(9th ed., Rev. 01.2024, November 2024).
The USPTO uses the sequence listings during the examination process
to determine the patentability of the invention claimed in the
application. The USPTO also uses the sequence listings for pre-grant
publication of applications and issued patents. Applicants use sequence
listings when preparing both national and international patent
applications that disclose nucleotide and/or amino acid sequences to
provide a written description of the invention and to distinguish the
claimed subject matter from the prior art.
This information covers only the submission of sequence listing
information itself. Information pertaining to the initial filing of a
U.S. patent application is collected under OMB Control Number 0651-
0032, and information pertaining to the initial filing of international
applications is collected under OMB Control Number 0651-0021.
For sequence listings filed as 37 CFR 1.825 amendments in
applications having a filing date of on or before June 30, 2022, this
information collection also accounts for the submission of a new or
substitute computer readable form (CRF) copy of the sequence listing
under 37 CFR 1.821(e) and 1.824, with the amendment incorporated
therein, if necessary, under 37 CFR 1.825(a)(5)(ii) or (b)(6)(ii).
Forms: None.
Type of Review: Extension and revision of a currently approved
information collection.
Affected Public: Public sector.
Respondent's Obligation: Required to obtain or retain benefits.
Frequency: On occasion.
Estimated Number of Annual Respondents: 30,000 respondents.
Estimated Number of Annual Responses: 30,000 responses.
Estimated Time per Response: The USPTO estimates that the responses
in this information collection will take the public approximately 6
hours to complete. This includes the time to gather the necessary
information, create the document, and submit the completed item(s) to
the USPTO.
Estimated Total Annual Respondent Burden Hours: 180,000 hours.
[[Page 48554]]
Estimated Total Annual Respondent Non-hourly Cost Burden: $336,973.
Justin Isaac,
Information Collections Officer, Office of the Chief Administrative
Officer, United States Patent and Trademark Office.
[FR Doc. 2025-19650 Filed 10-23-25; 8:45 am]
BILLING CODE 3510-16-P